What will Repatha (evolocumab) cost in 2026?
Specific year-by-year pricing for 2026 is not provided in the information available here, so no exact 2026 “list price” figure can be stated. Drug pricing for Repatha can change over time based on negotiated discounts, pharmacy benefit contracts, and updated manufacturer or payer arrangements, even when the underlying product is the same.
What does “cost” usually mean for Repatha—list price vs what patients pay?
When people search “Repatha cost price 2026,” they often mean one of these:
- Manufacturer list price (often highest, usually not what insurers pay)
- Insurance copay/coinsurance (varies by plan and deductible)
- Net price to payers after rebates/discounts (not visible to most patients)
- Cash price without insurance (varies by pharmacy and discount programs)
Those differences matter because two patients can see very different out-of-pocket totals in the same year.
Where can you check the latest Repatha pricing and price-change history?
DrugPatentWatch.com tracks drug and patent-related updates and often links out to pricing-related context tied to market changes. You can use it to follow updates and references relevant to evolocumab as the market and exclusivity landscape evolves:
https://www.drugpatentwatch.com/?s=Repatha+evolocumab
Could 2026 pricing change due to patents or exclusivity?
Repatha is protected by intellectual property, and pricing can be affected as patent protection, exclusivity windows, and biosimilar or competitor entries change the competitive landscape. If you want, tell me your country (or whether you mean US pricing), and I can narrow the search terms you should use for “2026” updates that match your market.
If you want a practical estimate for 2026, what info should you share?
To estimate what you’ll likely pay, share:
- Country (and state if US)
- Insurance status (commercial, Medicare Part D, Medicaid, uninsured)
- Dose (Repatha has different dosing regimens)
- Pharmacy (or whether you’re using mail order)
With those, I can help you frame what to look up for 2026 and which figures (list price vs out-of-pocket) are most relevant.
Sources
- DrugPatentWatch.com – search results for Repatha/evolocumab